Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Brunner HI
- Tzaribachev N
- Cornejo GV
- Joos R
- Gervais E
- Cimaz R
- Cuttica R
- Lutz T
- Quartier P
- Gandhi Y
- Nys M
- Wong R
- Martini A
- Lovell DJ
- Ruperto N
- Pediatric Rheumatology Collaborative Study Group and the Paediatric Rheumatology
Grupos
Abstract
Patients with polyarticular-course juvenile idiopathic arthritis (pJIA), receiving disease-modifying anti-rheumatic drugs with immunosuppressive effects, may be at increased risk of vaccine-preventable infections. This substudy assessed protective antibody responses to diphtheria and tetanus vaccination given prior to study enrolment in patients with pJIA.
Datos de la publicación
- ISSN/ISSNe:
- 1546-0096, 1546-0096
- Tipo:
- Article
- Páginas:
- 19-19
- PubMed:
- 32087715
- Factor de Impacto:
- 1,051 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Pediatric Rheumatology BMC
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- Abatacept, Biologic DMARDs, Juvenile idiopathic arthritis, Vaccination
Cita
Brunner HI,Tzaribachev N,Cornejo GV,Joos R,Gervais E,Cimaz R,CALVO I,Cuttica R,Lutz T,Quartier P,Gandhi Y,NYSM,Wong R,Martini A,Lovell DJ,Ruperto N,Pediatric Collaborative Study Group and the Paediatric R. Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept. Pediatr. Rheumatol. 2020. 18. (1):p. 19-19. IF:3,054. (2).
Portal de investigación